Login
Create An Account
Login
Create An Account
Search
View All
View All
All Categories
Critical Care, Anaesthetics & Emergency Medicine
Gerontology, Lifestyle Disease & Healthy Aging
Infectious Diseases, Vaccines & Antimicrobials
Ophthalmology
Paediatrics & Neonatology
Healthcare Alerts
Disease Outbreak Resources »
Cholera Outbreak Resources & Updates
The Medical Week in Review | Archive
Terms and Conditions of Use
Home
Contact Us
Search
Reset
Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2023
View Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2023
Currently reading
View Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2024
Novel Drugs & Emergent Therapeutics Archive 2023
Date
Source
Keywords
Company
Drug
Title & Link
20/09/23
Reuters
Allergy, Anaphylaxis
ARS Pharma
Neffy
US FDA declines to approve first nasal spray equivalent of EpiPen
19/09/23
Medical Professionals Reference
Atopic Dermatitis
Arcutis
Roflumilast
Roflumilast Cream Effective in Pediatric Atopic Dermatitis Trial
23/02/23
BioPharmDive
Haemophilia
Sanofi
Altuviiio
FDA approves Sanofi’s long-lasting hemophilia drug
18/11/22
European Pharmaceutica Review
Diabetes, Paediatrics, FDA
Provention Bio
Tzield
Tzield: FDA approves first drug to delay type 1 diabetes
18/08/22
Medical Professional References
Haematology, Biologics
BlueBird Bio
Zynteglo
Zynteglo Approved as First Gene Therapy for Beta-Thalassemia
18/03/22
Marinus Pharmaceutical
Rare Diseases, CDKL5 Epilepsy
Marinus
ZTALMY® (ganaxolone)
Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder
.
Rate
Viewed
Bookmark
Print
Rating
Rating Value
Most Viewed Articles
All That Remains: A Renowned Forensic Scientist on Death, Mortality, and Solving Crimes
Nov 17, 2023
MNG004-World Health Organisation requests information from China regarding outbreak of respiratory diseases
Nov 23, 2023
CDC Flags BA.2.86 COVID Variant
Dec 04, 2023
Rate This Media
×
1
2
3
4
5
Home
Contact Us
Log in
Powered by eLecture, a VisualLive Solution
© Copyright 2024
Terms of Use
Disclaimer
We use cookies to track how our site is used, but do not store any personal data. For more information, please review our Terms and Conditions.
I agree